Plasma concentrations of these 17 biomarkers or CRP did not exhibit any obvious correlation to the sleep quality measured by the aggregated MOS score within this cohort, suggesting that both the regulation of these biomarkers as well as sleep physiology is complex in cancer patients and that sleep disruption cannot be accurately predicted by any single biomarker. Here, CRP is linked to cancer.